Skip to main navigation Skip to search Skip to main content

Established and Emerging Trends in Computational Drug Discovery in the Structural Genomics Era

  • Olivier Taboureau
  • , Jonathan B. Baell
  • , Juan Fernández-Recio
  • , Bruno O. Villoutreix
    • University of Melbourne
    • Barcelona Supercomputing Center-Centro Nacional de Supercomputación
    • Université Paris Cité

    Research output: Contribution to journalJournal articleResearchpeer-review

    Abstract

    Bioinformatics and chemoinformatics approaches contribute to hit discovery, hit-to-lead optimization, safety profiling, and target identification and enhance our overall understanding of the health and disease states. A vast repertoire of computational methods has been reported and increasingly combined in order to address more and more challenging targets or complex molecular mechanisms in the context of large-scale integration of structure and bioactivity data produced by private and public drug research. This review explores some key computational methods directly linked to drug discovery and chemical biology with a special emphasis on compound collection preparation, virtual screening, protein docking, and systems pharmacology. A list of generally freely available software packages and online resources is provided, and examples of successful applications are briefly commented upon.
    Original languageEnglish
    JournalChemistry and Biology
    Volume19
    Issue number1
    Pages (from-to)29-41
    ISSN1074-5521
    DOIs
    Publication statusPublished - 2012

    Fingerprint

    Dive into the research topics of 'Established and Emerging Trends in Computational Drug Discovery in the Structural Genomics Era'. Together they form a unique fingerprint.

    Cite this